Pardes Biosciences, Inc.
-
Ticker
PRDS
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Carlsbad, California
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing an oral antiviral treatment for COVID-19. Following the suspension of its clinical development activities, the Company is exploring a range of strategic alternatives.
Pardes Biosciences, Inc.
Most Recent Annual Report
MOST RECENT
2022 Annual Report and Form 10K
Older/Archived Annual Reports